Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

A Clinical Evaluation of the RheOx Bronchial Rheoplasty System

NCT: NCT05641207 · COMPLETED

NCT IDNCT05641207

StatusCOMPLETED

Start Date2023-05-18

Completion2026-06-30

SponsorEnergenx Medical LTD. (INDUSTRY)

First posted2022-12-07

Last updated2026-08-21

Brief Summary

This is a prospective, multicenter, single arm and open-label clinical trial to evaluate the performance, effectiveness and safety of RheOx™ system in the treatment of the symptoms of chronic bronchitis in adult moderate to severe COPD patients.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑